Use of Name, Registry and Reporting 5 Clause Samples

The 'Use of Name, Registry and Reporting' clause governs how parties may use each other's names, trademarks, or other identifying information, and outlines requirements for maintaining records and providing reports. Typically, this clause restricts one party from using the other's name in advertising or public statements without prior consent, and may require accurate record-keeping of activities or transactions related to the agreement. Its core function is to protect the reputation and confidentiality of the parties while ensuring transparency and accountability through proper documentation and reporting.
Use of Name, Registry and Reporting 5. 5. Použitie mien a názvov, registrácia No Party hereto shall use any other Party’s name, or Sponsor’s name, in connection with any advertising, publication or promotion Žiadna zo zmluvných strán nepoužije názov druhej zmluvnej strany ani názov zadávateľa v súvislosti s reklamou, publikovaním alebo without prior written permission, except that the Sponsor and IQVIA may use the Site’s name in Study publications and communications, including clinical trial websites and Study newsletters. Sponsor will register the Study with a public clinical trials registry in accordance with Applicable Laws and will report the results of the Study publicly when and to the extent required by Applicable Laws. propagáciou bez predchádzajúceho písomného povolenia; zadávateľ a spoločnosť IQVIA však môžu používať názov pracoviska skúšania v publikáciách zo skúšania a v mediálnej komunikácii, vrátane webových stránok venovaných klinickým skúšaniam a tlačových oznámení o skúšaní. Zadávateľ zaregistruje skúšanie vo verejnom registri klinických skúšaní v súlade s platnými právnymi predpismi a zverejní správu z výsledkov skúšania v takom termíne a rozsahu, v akom to požadujú platné právne predpisy.
View SourceView Similar (6)
Use of Name, Registry and Reporting 5. 1 Použitie mien a názvov, registrácia a správy zo skúšania No Party hereto shall use any other Party’s name, or Sponsor’s name, in connection with any advertising, publication or promotion without prior written permission, except that the Sponsor and IQVIA may use the Institution’s name in Study publications and communications, including clinical trial websites and Study newsletters. Sponsor will register the Study with a public clinical trials registry in accordance with applicable laws and regulations and will report the results of the Study publicly when and to the extent required by applicable laws and regulations. Žiadna zo zmluvných strán nepoužije názov druhej zmluvnej strany ani názov zadávateľa v súvislosti s reklamou, publikovaním alebo propagáciou bez predchádzajúceho písomného povolenia; zadávateľ a spoločnosť IQVIA však môžu používať meno zdravotníckeho zariadenia v publikáciách zo skúšania a v mediálnej komunikácii, vrátane webových stránok venovaných klinickým skúšaniam a tlačových oznámení o skúšaní. Zadávateľ zaregistruje skúšanie vo verejnom registri klinických skúšaní v súlade s platnými právnymi predpismi a zverejní správu z výsledkov skúšania v takom termíne a rozsahu, v akom to požadujú platné právne predpisy. VXA34987 CTA Template Slovakia INST 6Dec2016- based on IQVIA Global template – 15 April 2013 PI: ▇▇▇▇▇ ▇▇▇▇▇, MD VXA34987 CTA Template Slovakia INST 6Dec2016- based on IQVIA Global template – 15 April 2013
View SourceView Similar (4)
Use of Name, Registry and Reporting 5. 5. Použitie mien a názvov, registrácia a správy zo skúšania
View Source

Related to Use of Name, Registry and Reporting 5

  • Use of Name and Reports Without the Advisor’s prior written consent, neither the Company nor any of its affiliates (nor any director, officer, manager, partner, member, employee or agent thereof) shall quote or refer to (i) the Advisor’s name or (ii) any advice rendered by the Advisor to the Company or any communication from the Advisor in connection with performance of their services hereunder, except as required by applicable federal or state law, regulation or securities exchange rule.

  • Use of FIIOC’s and FSC's Name The Trust shall not use the name of FIIOC and FSC in any Prospectus, sales literature or other material relating to the Trust or any Fund of the Trust in a manner not consented to by FIIOC and FSC prior to use; provided, however, that FIIOC and FSC shall approve all uses of its name which merely refer in accurate terms to its appointments, duties or fees hereunder or which are required by the Securities and Exchange Commission ("SEC" or “Commission”) or a state securities commission; and further, provided that in no event shall such approval be unreasonably withheld.

  • ACCESS TO SECURITY LOGS AND REPORTS Upon request, the Contractor shall provide access to security logs and reports to the State or Authorized User in a format as specified in the Authorized User Agreement.

  • Publicity and Reports Company, Bank, and Seller shall coordinate all publicity relating to the transactions contemplated by this Agreement and no Party shall issue any press release, publicity statement or other public notice relating to this Agreement or any of the transactions contemplated hereby without obtaining the prior consent of the other Party, except to the extent that legal counsel to any Party shall deliver a written opinion to the other Party to the effect that a particular action is required by applicable Rules.

  • Identification of Data a. All Background, Third Party Proprietary and Controlled Government Data provided by Disclosing Party shall be identified in the Annex under which it will be provided. b. NASA software and related Data provided to Partner shall be identified in the Annex under which it will be used. Notwithstanding H.4., Software and related Data will be provided to Partner under a separate Software Usage Agreement (SUA). Partner shall use and protect the related Data in accordance with this Article. Unless the SUA authorizes retention, or Partner enters into a license under 37 C.F.R. Part 404, the related Data shall be disposed of as instructed by NASA.